Back to search

Article

Determination of Slow-binding HDAC Inhibitor Potency and Subclass Selectivity

2021-12-18

Abstract excerpt

<h4>ABSTRACT</h4> Histone deacetylases (HDACs) 1–3 regulate chromatin structure and gene expression. These three enzymes are targets for cancer chemotherapy and are studied for the treatment of immune disorders and neurodegeneration, but there is a lack of selective pharmacological tool compounds to unravel their individual roles. Potent inhibitors of HDACs 1–3 often display slow-binding kinetics, which causes a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
306fbb4c-0c91-577d-8c26-1116b4ca6cf7
DOI
10.1101/2021.12.18.473277
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determination of Slow-binding HDAC Inhibitor Potency and Subclass SelectivityDOI 10.1101/2021.12.18.473277
Select a neighboring publication to make it the new centre.